HDAC9 and neoplasm: There isn’t known selective inhibitor of HDAC7, but the selective class IIa HDAC inhibitor (TMP195) has been well-characterized to inhibit HDAC7 [26, 30, 31], with reported anti-tumor activities in preclinical studies [32].